Recommendation ID IPG650/1 Question The evidence on percutaneous insertion of a cerebral protection device to prevent cerebral embolism
Recommendation ID IPG651/2 Question Current evidence on the safety of percutaneous mechanical thrombectomy for acute deep vein thrombosis
Recommendation ID IPG651/1 Question Current evidence on the safety of percutaneous mechanical thrombectomy for acute deep vein thrombosis
Recommendation ID IPG654/1 Question The evidence on the safety of reinforcement of a permanent stoma with a synthetic or biological mesh
Recommendation ID IPG644/1 Question Current evidence on the safety and efficacy of radially emitting laser fibre treatment of an anal fistula
Recommendation ID IPG658/1 Question Current evidence on the safety and efficacy of endovascular insertion of an intrasaccular wire-mesh
Recommendation ID IPG655 Question The evidence on cardiac contractility modulation device implantation for heart failure raises no major
Recommendation ID IPG659/1 Question Current evidence on the safety and efficacy of low-energy contact X‑ray brachytherapy (the Papillon
Recommendation ID IPG660/1 Question Current evidence on the safety and efficacy of implant insertion for prominent ears is inadequate in
Recommendation ID IPG661/1 Question Evidence on the safety and efficacy of high-intensity focused ultrasound for glaucoma is inadequate
Recommendation ID IPG652/1 Question Current evidence on the safety and efficacy of bronchoscopic thermal vapour ablation for upper-lobe
Find out more about NICE technology appraisals advisory committee D members
Our European health technology assessment and regulatory concurrent advice service is designed to provide scientific advice from NICE within similar...
Advice on the use of Leukomed Sorbact for preventing surgical site infection (SSI) to aid local decision making
In Dudley over the last 15 years we have used a variety of engagement strategies to work with primary care clinicians to address the premature mortality from hypertension related diseases
Everything NICE has said assessing and managing melanoma in an interactive flowchart
A quick guide to NICE resources for social care
Evidence-based recommendations on rapid tests for group A streptococcal (strep A) infections in people aged 5 and over with a sore throat
Evidence-based recommendations on rucaparib (Rubraca) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer that has responded to
Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast
Everything NICE has said on reducing the risk of excess winter deaths and illness associated with cold homes in an interactive flowchart
This agreement relates to: Tezacaftor and ivacaftor (Symkevi®) in combination with ivacaftor (kalydeco) for treating cystic fibrosis patients who are
As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
Everything NICE has said on urogenital conditions in an interactive flowchart
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
Recommendation ID NG140/4 Question For women who are having medical abortion between 10+1 and 12+0 weeks, what is the efficacy and acceptability